Phio Pharmaceuticals Corp reports results for the quarter ended in December - Earnings Summary

Phio Pharmaceuticals

22/03/2023 21:46

* Phio Pharmaceuticals Corp  PHIO.OQ  reported a quarterly
adjusted loss of $2.40​​ per share for the quarter ended in
December. The lone analyst forecast for the quarter was for a
loss of $3.24 per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Phio Pharmaceuticals Corp's reported EPS for the quarter
was a
loss of $2.40​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Phio Pharmaceuticals Corp shares had risen by 25.7% this
quarter.
    * The company reported a quarterly loss of $2.73 million.
    * Wall Street's median 12-month price target for Phio
Pharmaceuticals Corp is $72.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 22 at 09:46 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -3.24          -2.40          Beat
 Sep. 30 2022      4.32           -3.12          Missed
 Jun. 30 2022      -3.72          -2.28          Beat
 Mar. 31 2022      -3.60          -2.28          Beat